Thermo Fisher Scientific (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,254,000 | 9,852,000 | 1,982,000 | 4,576,000 | 4,134,000 |
| Marketable Securities | 2,000 | 253,000 | 1,564,000 | 1,814,000 | 1,813,000 |
| Receivables | 9,204,000 | 8,900,000 | 8,911,000 | 8,594,000 | 8,455,000 |
| Inventories | 5,496,000 | 5,425,000 | 5,745,000 | 5,559,000 | 5,224,000 |
| Other current assets | 4,360,000 | 4,277,000 | 4,093,000 | 4,041,000 | 3,752,000 |
| TOTAL | $22,316,000 | $28,707,000 | $22,295,000 | $24,584,000 | $23,378,000 |
| Non-Current Assets | |||||
| PPE Net | 10,658,000 | 10,565,000 | 10,177,000 | 9,635,000 | 9,331,000 |
| Intangibles | 74,333,000 | 65,200,000 | 65,529,000 | 62,397,000 | 61,816,000 |
| Other Non-Current Assets | 5,973,000 | 5,871,000 | 5,019,000 | 4,615,000 | 4,516,000 |
| TOTAL | $90,964,000 | $81,636,000 | $80,725,000 | $76,647,000 | $75,663,000 |
| Total Assets | $113,281,000 | $110,343,000 | $103,020,000 | $101,230,000 | $99,041,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,344,000 | 3,622,000 | 3,120,000 | 2,980,000 | 3,049,000 |
| Accrued Expenses | 1,565,000 | 1,995,000 | 1,884,000 | 1,518,000 | 1,419,000 |
| Other current liabilities | 2,928,000 | 2,710,000 | 2,852,000 | 2,805,000 | 2,866,000 |
| TOTAL | $14,621,000 | $15,189,000 | $14,888,000 | $12,718,000 | $13,174,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 40,071,000 | 35,852,000 | 31,857,000 | 33,015,000 | 31,370,000 |
| Other Non-Current Liabilities | 4,537,000 | 4,389,000 | 4,402,000 | 4,394,000 | 4,095,000 |
| TOTAL | $46,720,000 | $41,740,000 | $37,106,000 | $38,035,000 | $36,510,000 |
| Total Liabilities | $61,341,000 | $56,928,000 | $51,996,000 | $50,754,000 | $49,684,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 371,622 | 371,484 | 375,708 | 377,612 | 377,494 |
| Common Shares | 445,000 | 445,000 | 445,000 | 444,000 | 444,000 |
| Retained earnings | 60,632,000 | 59,156,000 | 57,354,000 | 55,901,000 | 54,447,000 |
| Other shareholders' equity | -2,490,000 | -2,440,000 | -2,795,000 | -2,832,000 | -2,376,000 |
| TOTAL | $51,940,000 | $53,415,000 | $51,024,000 | $50,476,000 | $49,357,000 |
| Total Liabilities And Equity | $113,281,000 | $110,343,000 | $103,020,000 | $101,230,000 | $99,041,000 |